Blood component therapy: Which, when and how much

Journal of Anaesthesiology Clinical Pharmacology

Volumn 27, Issue 2, 2011, Pages 278-284

  Arya, Rajesh Chand ^a   Wander, G S ^a   Gupta, Pankaj ^b  

^a Hero DMC Heart Institute   (India)

^b ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

Author keywords

Bleeding disorder; Blood components; Blood transfusion; Coagulopathy

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE; BLOOD CLOTTING FACTOR 9 COMPLEX; DENDRITIC CELL VACCINE; DIMETHYL SULFOXIDE; FIBRIN GLUE; FLUOROCARBON; FRESH FROZEN PLASMA; HEMOGLOBIN; IMMUNOGLOBULIN; LIPOSOME; MICROSPHERE;

ANEMIA; APHERESIS; ARTICLE; B CELL LEUKEMIA; BACTERIAL INFECTION; BLOOD BANK; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD COMPONENT THERAPY; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CENTRIFUGATION; CHRONIC LYMPHATIC LEUKEMIA; CRYOPRECIPITATE; CRYOPRESERVATION; DISSEMINATED INTRAVASCULAR CLOTTING; DONOR LYMPHOCYTE INFUSION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FREEZE DRYING; GAMMA IRRADIATION; GUILLAIN BARRE SYNDROME; HEALTH CARE ORGANIZATION; HEMOLYTIC UREMIC SYNDROME; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOFIBRINOGENEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; LEUKOPENIA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; STORAGE TEMPERATURE; THROMBOCYTE MEMBRANE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT INDICATION; VON WILLEBRAND DISEASE;

EID: 79958713628     PISSN: 09709185     EISSN: None     Source Type: Journal    
DOI: 10.4103/0970-9185.81849     Document Type: Article

References (14)

1. Practice Guidelines for Perioperative Blood Transfusion and Adjuvant Therapies: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198-208.
2. Stehling L, Luban NL, Anderson KC, Sayers MH, Long A, Attar S, et al. Guidelines for blood utilization review. Transfusion 1994;34:438-448.
3. Despotis GJ, Grishaber JE, Goodnough LT: The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion 1994;34:290-296.
4. Paone G, Spencer T, Silverman NA: Blood conservation in coronary artery surgery. Surgery 1994;116:672-678.
5. Wallace EL, Surgenor DM, Hao HS, An J, Chapman RH, Churchill WH: Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993;33:139-144.
6. Standl T. Haemoglobin-based erythrocyte transfusion substitutes. Expert Opin Biol Ther 2001;1:831-843.
7. Water JA, Trouwborst A, Spense RK. A pilot study of the effects of perflubron emulsion, AF0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth Analg 1996;82:103-107.
8. Consensus conference. Platelet transfusion therapy. JAMA 1987;257:1777-1780.
9. Bode AP. Preclinical testing of lyophilized platelets as a product for transfusion medicine. Transfus Sci 1995;16:183-185.
10. Bode AP, Read MS. Lyophilized platelets: Continued development. Transfus Sci 2000;22:99-105.
11. Chao FC, Kim BK, Houranieh AM, Liang FH, Konrad MW, Swisher SN, et al. Infusible platelet membrane microvesicles: A potential transfusion substitute for platelets. Transfusion 1996;36:536-542.
12. Hehne HJ, Nyman HB, Burri M, Wolfe G. Management of bleeding disorders in traumatic-haemorrhagic shock states with deep frozen fresh plasma. Eur J Intensive Care Med 1979;2:157-161.
13. College of American Pathologists: Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA 1994;271:777-781.
14. Swenson MR. Autoimmunity and immunotherapy. J IV Nuts 2000;23:SB-13.